Cgmp requirements for compressed air

In the field of drug production, compressed air is a key public medium, and its quality is directly related to the safety and effectiveness of drugs. In order to ensure that compressed air meets drug production specifications, a control system needs to be established from the following dimensions:

1. Core quality standards

1. cleanliness control
   • Particulate matter restriction: The content of particulate matter with a diameter of>0.1μm in compressed air must be ≤3,500 particles/m³ to avoid particulate pollution of drugs.
   • microbial control: After passing through a 0.22μm sterilization filter, the microbial load of the compressed air needs to be <1CFU/m³ to prevent microorganisms from contaminating the sterile preparation.
2. Oil content control
   • For compressed air that directly comes into contact with drugs, the total oil content needs to be ≤0.01mg/m³, which is achieved by using an oil-free air compressor or a post-mounted activated carbon filter device.
3. Water content management
   • The pressure dew point needs to be ≤-20℃, which is achieved by a freeze dryer or an adsorption dryer to avoid moisture condensation leading to drug deterioration or equipment corrosion.

2. System design specifications

1. Material compatibility
   • Pipelines and valves that come into contact with compressed air must be made of 316L stainless steel or PTFE coated material to avoid metal ions escaping and polluting drugs.
   • Seals must be made of non-toxic materials such as EPDM or silicone, which comply with FDA 21 CFR 177.2600.
2. hydrodynamic design
   • The pipeline layout avoids blind pipes, and the dead corner length is ≤1.5 times the pipe diameter to ensure complete gas replacement.
   • Terminal filters are equipped with key gas points, with a filtering accuracy of 0.01μm, achieving point-to-point protection.
3. Cleanability design
   • The system supports in-line steam sterilization (SIP) or CIP cleaning, and has a temperature resistance of ≥121℃, meeting the cleaning verification requirements.
   • The drainage device adopts automatic steam traps to avoid the risk of pollution caused by manual operation.

3. Operation and maintenance requirements

1. daily monitoring
   • Measure the pressure, temperature and water content of compressed air every day, record the data and draw a trend chart.
   • Microbial challenge tests were conducted every week and cultured with R2A medium at 30-35℃ for 5 days to confirm that no colonies grew.
2. preventive maintenance
   • The air filter element is replaced every 2000 hours, and integrity testing is carried out before and after replacement.
   • The regeneration cycle of the dryer is carried out according to the equipment manual, and the accuracy of the dew point meter is checked regularly.
3. change control
   • System modifications or component replacements require a change process to evaluate the impact on drug quality.
   • The introduction of new equipment requires DQ (Design Qualification), IQ (Installation Qualification), OQ (Operational Qualification), and PQ (Performance Qualification).

4. Key management and control points for typical application scenarios

V. Quality traceability and continuous improvement

1. electronic batch record
   • Compressed air quality data is incorporated into the electronic batch record system to achieve traceability of the production process.
   • Abnormal data triggers the deviation investigation process to clarify the root cause and formulate corrective measures.
2. annual quality review
   • The quality of the compressed air system is reviewed every year to analyze parameters such as filter life and dryer efficiency.
   • Optimize maintenance plans based on data trends, such as adjusting filter replacement cycles or dryer regeneration temperatures.

conclusion
Pharmaceutical production companies need to establish a quality management system covering the entire chain of “production-transportation-use” of compressed air, and ensure that the quality of compressed air continues to meet drug production requirements through scientific design, rigorous maintenance and continuous monitoring. With the improvement of regulatory requirements, companies should actively introduce technical means such as smart sensors and big data analysis to achieve real-time early warning and lean management of compressed air quality and provide a solid guarantee for drug quality and safety.